You are on page 1of 1

Using recombinant deoxyribonucleic acid (rDNA) technologies, scientists

have been able to develop three types of recombinant vaccines: (1) live
genetically modified organisms, (2) recombinant inactivated (“killed”)
vaccines, and (3) genetic vaccines. These vaccines no longer cause
disease, but still induce a strong immune response. Paralleling the
development of new, more efficacious, stable, and safe recombinant
vaccines has been the study of vaccine delivery methods and
immunostimulating adjuvant compounds that enhance the immune
response.

You might also like